Medios AG | Finanzwire

Basculer en Français

8296	Companies
114899	Keywords
55320	Articles
62454	Press releases

Home
Companies
Medios AG

BRIEF

published on 11/12/2024 at 08:46, 9 days 4 hours ago

Medios AG Achieves Record Third Quarter in 2024

Medios AG Earnings Growth Financial Outlook Q3 2024 Specialty Pharma
PRESS RELEASE

published on 11/12/2024 at 08:41, 9 days 4 hours ago

Medios AG reports record quarter Q3 2024 with significant increase in earnings and margins
Medios AG reports record quarter Q3 2024 with significant increase in earnings and margins. EBITDA pre1 reaches €24.6 million (+42.9%) and revenue in the nine-month period up 4.2%

Revenue Growth Medios AG Earnings Increase EBITDA Pre1 Record Quarter
BRIEF

published on 08/14/2024 at 14:56, 3 months 6 days ago

Medios AG Expands Supervisory Board to Five Members

Annual General Meeting Sustainable Growth Supervisory Board Medios AG ESG Committee
PRESS RELEASE

published on 08/14/2024 at 14:51, 3 months 6 days ago

Medios AG: Annual General Meeting resolves to expand the Supervisory Board to five members
Medios AG Annual General Meeting expands Supervisory Board to five members. Shareholders approve growth strategy and new Board members

Growth Strategy Shareholders Supervisory Board AGM Medios AG
BRIEF

published on 08/13/2024 at 07:48, 3 months 8 days ago

Medios AG Shows Strong Growth in First Half of 2024

EBITDA Medios AG Pharmaceutical Supply 2024 Growth Ceban Acquisition
PRESS RELEASE

published on 08/13/2024 at 07:43, 3 months 8 days ago

Medios AG continues its growth trajectory in the first half of 2024 and records disproportionately high increase in earnings
Medios AG continues its growth trajectory in the first half of 2024, with revenue up by 6.3% and EBITDA pre1 by 7.3%. Successful acquisition of Ceban and optimistic outlook for 2024

Revenue Increase Medios AG Growth Trajectory Ceban Acquisition EBITDA Pre1
BRIEF

published on 08/05/2024 at 10:37, 3 months 16 days ago

Medios Expands Advanced Therapies and Appoints Dr. Andreas Schmiede as VP

Medios AG Advanced Therapies Personalized Medicine Specialty Pharma Dr. Andreas Schmiede
PRESS RELEASE

published on 08/05/2024 at 10:32, 3 months 16 days ago

Medios expands „Advanced Therapies“ field and appoints Dr. Andreas Schmiede as Vice President
Medios AG strengthens activities in Advanced Therapies field, appoints Dr. Andreas Schmiede as Vice President. Focus on personalized medicine innovations and patient access to cutting-edge therapies

Medios AG Advanced Therapies Personalized Medicine Dr. Andreas Schmiede Pharmaceutical Innovations
BRIEF

published on 07/01/2024 at 09:37, 4 months 20 days ago

“Hauptstadtkongress 2024”: Medios Hosts Symposium on 'Security of Supply'

Healthcare System Medios AG Specialty Pharma Hauptstadtkongress 2024 Security Of Supply
PRESS RELEASE

published on 07/01/2024 at 09:32, 4 months 20 days ago

“Hauptstadtkongress 2024”: Medios hosts symposium on 'Security of supply”
Medios AG participated in 'Hauptstadtkongress 2024', focusing on 'Security of supply'. Experts discussed challenges in patient care and the importance of cooperation in Specialty Pharma sector

Healthcare System Medios AG Specialty Pharma Hauptstadtkongress 2024 Security Of Supply

1 2 ... 4

Accesswire

Published on 11/21/2024 at 13:00, 25 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 25 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 25 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 25 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 25 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 10 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 50 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 10 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 19 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 25 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 27 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 5 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 40 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 40 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE